5-HT5A receptor explained
5-Hydroxytryptamine (serotonin) receptor 5A, also known as HTR5A, is a protein that in humans is encoded by the HTR5A gene.[1] [2] Agonists and antagonists for 5-HT receptors, as well as serotonin uptake inhibitors, present promnesic (memory-promoting) and/or anti-amnesic effects under different conditions, and 5-HT receptors are also associated with neural changes.
Function
The gene described in this record is a member of 5-hydroxytryptamine receptor family and encodes a multi-pass membrane protein that functions as a receptor for 5-hydroxytryptamine and couples to G proteins, negatively influencing cAMP levels via Gi and Go.[3] This protein has been shown to function in part through the regulation of intracellular Ca2+ mobilization.[1] The 5-HT5A receptor has been shown to be functional in a native expression system.[4]
Rodents have been shown to possess two functional 5-HT5 receptor subtypes, 5-HT5A and 5-HT5B,[5] however while humans possess a gene coding for the 5-HT5B subtype, its coding sequence is interrupted by stop codons, making the gene non-functional, and so only the 5-HT5A subtype is expressed in human brain.[6]
It also appears to serve as a presynaptic serotonin autoreceptor.[7]
Clinical significance
The neurotransmitter serotonin (5-hydroxytryptamine, 5-HT) has been implicated in a wide range of psychiatric conditions and also has vasoconstrictive and vasodilatory effects.[1]
Selective ligands
Few highly selective ligands are commercially available for the 5-HT5A receptor. When selective activation of this receptor is desired in scientific research, the non-selective serotonin receptor agonist 5-Carboxamidotryptamine can be used in conjunction with selective antagonists for its other targets (principally 5-HT1A, 5-HT1B, 5-HT1D, and 5-HT7). Research in this area is ongoing.[8] [9]
Agonists
Antagonists
See also
Further reading
- Raymond JR, Mukhin YV, Gelasco A, Turner J, Collinsworth G, Gettys TW, Grewal JS, Garnovskaya MN . 6 . Multiplicity of mechanisms of serotonin receptor signal transduction . Pharmacology & Therapeutics . 92 . 2–3 . 179–212 . 2002 . 11916537 . 10.1016/S0163-7258(01)00169-3 .
- Thomas DR . 5-ht5A receptors as a therapeutic target . Pharmacology & Therapeutics . 111 . 3 . 707–714 . September 2006 . 16516972 . 10.1016/j.pharmthera.2005.12.006 .
- Rees S, den Daas I, Foord S, Goodson S, Bull D, Kilpatrick G, Lee M . Cloning and characterisation of the human 5-HT5A serotonin receptor . FEBS Letters . 355 . 3 . 242–246 . December 1994 . 7988681 . 10.1016/0014-5793(94)01209-1 . 36425845 . free .
- Schanen NC, Scherer SW, Tsui LC, Francke U . Assignment of the 5-hydroxytryptamine (serotonin) receptor 5A gene (HTR5A) to human chromosome band 7q36.1 . Cytogenetics and Cell Genetics . 72 . 2–3 . 187–188 . 1997 . 8978771 . 10.1159/000134184 . free . 10722/42533 .
- Toward a complete human genome sequence . Genome Research . 8 . 11 . 1097–1108 . November 1998 . 9847074 . 10.1101/gr.8.11.1097 . free . The Washington University Genome Sequencing Cente . The Sanger Centre .
- Francken BJ, Josson K, Lijnen P, Jurzak M, Luyten WH, Leysen JE . Human 5-hydroxytryptamine(5A) receptors activate coexpressed G(i) and G(o) proteins in Spodoptera frugiperda 9 cells . Molecular Pharmacology . 57 . 5 . 1034–1044 . May 2000 . 10779389 .
- Marazziti D, Ori M, Nardini M, Rossi A, Nardi I, Cassano GB . mRNA expression of serotonin receptors of type 2C and 5A in human resting lymphocytes . Neuropsychobiology . 43 . 3 . 123–126 . 2001 . 11287788 . 10.1159/000054878 . 20724896 .
- Iwata N, Ozaki N, Inada T, Goldman D . Association of a 5-HT(5A) receptor polymorphism, Pro15Ser, to schizophrenia . Molecular Psychiatry . 6 . 2 . 217–219 . March 2001 . 11317225 . 10.1038/sj.mp.4000829 . free .
- Grailhe R, Grabtree GW, Hen R . Human 5-HT(5) receptors: the 5-HT(5A) receptor is functional but the 5-HT(5B) receptor was lost during mammalian evolution . European Journal of Pharmacology . 418 . 3 . 157–167 . April 2001 . 11343685 . 10.1016/S0014-2999(01)00933-5 .
- Noda M, Yasuda S, Okada M, Higashida H, Shimada A, Iwata N, Ozaki N, Nishikawa K, Shirasawa S, Uchida M, Aoki S, Wada K . 6 . Recombinant human serotonin 5A receptors stably expressed in C6 glioma cells couple to multiple signal transduction pathways . Journal of Neurochemistry . 84 . 2 . 222–232 . January 2003 . 12558985 . 10.1046/j.1471-4159.2003.01518.x . 7364018 . free .
- Khorana N, Smith C, Herrick-Davis K, Purohit A, Teitler M, Grella B, Dukat M, Glennon RA . 6 . Binding of tetrahydrocarboline derivatives at human 5-HT5A receptors . Journal of Medicinal Chemistry . 46 . 18 . 3930–3937 . August 2003 . 12930153 . 10.1021/jm030080s .
- Dietz BM, Mahady GB, Pauli GF, Farnsworth NR . Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro . Brain Research. Molecular Brain Research . 138 . 2 . 191–197 . August 2005 . 15921820 . 5805132 . 10.1016/j.molbrainres.2005.04.009 .
External links
- Web site: 5-ht5a . IUPHAR Database of Receptors and Ion Channels . International Union of Basic and Clinical Pharmacology .
Notes and References
- Web site: Entrez Gene: HTR5A 5-hydroxytryptamine (serotonin) receptor 5A.
- Rees S, den Daas I, Foord S, Goodson S, Bull D, Kilpatrick G, Lee M . Cloning and characterisation of the human 5-HT5A serotonin receptor . FEBS Letters . 355 . 3 . 242–246 . December 1994 . 7988681 . 10.1016/0014-5793(94)01209-1 . 36425845 . free .
- Francken BJ, Jurzak M, Vanhauwe JF, Luyten WH, Leysen JE . The human 5-ht5A receptor couples to Gi/Go proteins and inhibits adenylate cyclase in HEK 293 cells . European Journal of Pharmacology . 361 . 2–3 . 299–309 . November 1998 . 9865521 . 10.1016/S0014-2999(98)00744-4 .
- Goodfellow NM, Bailey CD, Lambe EK . The native serotonin 5-HT(5A) receptor: electrophysiological characterization in rodent cortex and 5-HT(1A)-mediated compensatory plasticity in the knock-out mouse . The Journal of Neuroscience . 32 . 17 . 5804–5809 . April 2012 . 22539842 . 4644074 . 10.1523/JNEUROSCI.4849-11.2012 .
- Matthes H, Boschert U, Amlaiky N, Grailhe R, Plassat JL, Muscatelli F, Mattei MG, Hen R . 6 . Mouse 5-hydroxytryptamine5A and 5-hydroxytryptamine5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization . Molecular Pharmacology . 43 . 3 . 313–319 . March 1993 . 8450829 .
- Nelson DL . 5-HT5 receptors . Current Drug Targets. CNS and Neurological Disorders . 3 . 1 . 53–58 . February 2004 . 14965244 . 10.2174/1568007043482606 .
- Thomas DR, Soffin EM, Roberts C, Kew JN, de la Flor RM, Dawson LA, Fry VA, Coggon SA, Faedo S, Hayes PD, Corbett DF, Davies CH, Hagan JJ . 6 . SB-699551-A (3-cyclopentyl-N-[2-(dimethylamino)ethyl]-N-[(4'-{[(2-phenylethyl)amino]methyl}-4-biphenylyl)methyl]propanamide dihydrochloride), a novel 5-ht5A receptor-selective antagonist, enhances 5-HT neuronal function: Evidence for an autoreceptor role for the 5-ht5A receptor in guinea pig brain . Neuropharmacology . 51 . 3 . 566–577 . September 2006 . 16846620 . 10.1016/j.neuropharm.2006.04.019 . 543423 .
- Wesołowska A . In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors . Polish Journal of Pharmacology . 54 . 4 . 327–341 . 2002 . 12523486 .
- Peters JU, Lübbers T, Alanine A, Kolczewski S, Blasco F, Steward L . Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: optimising brain penetration . Bioorganic & Medicinal Chemistry Letters . 18 . 1 . 262–266 . January 2008 . 18023344 . 10.1016/j.bmcl.2007.10.078 .
- The RBI Handbook of Receptor Classification and Signal Transduction, page 114 (1995)
- Zhang S, Chen H, Zhang C, Yang Y, Popov P, Liu J, Krumm BE, Cao C, Kim K, Xiong Y, Katritch V, Shoichet BK, Jin J, Fay JF, Roth BL . 6 . Inactive and active state structures template selective tools for the human 5-HT5A receptor . Nature Structural & Molecular Biology . 29 . 7 . 677–687 . July 2022 . 35835867 . 9299520 . 10.1038/s41594-022-00796-6 .
- Dietz BM, Mahady GB, Pauli GF, Farnsworth NR . Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro . Brain Research. Molecular Brain Research . 138 . 2 . 191–197 . August 2005 . 15921820 . 5805132 . 10.1016/j.molbrainres.2005.04.009 .
- [Bryan Roth|Roth BL]
- Ray TS . Psychedelics and the human receptorome . PLOS ONE . 5 . 2 . e9019 . February 2010 . 20126400 . 2814854 . 10.1371/journal.pone.0009019 . free . 2010PLoSO...5.9019R .
- Garcia-Ladona FJ, Szabo L, Steiner G, Hofmann HP . 2004-06-15 . Use of 5-HT5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances . US . 6750221.
- Yamazaki M, Okabe M, Yamamoto N, Yarimizu J, Harada K . Novel 5-HT5A receptor antagonists ameliorate scopolamine-induced working memory deficit in mice and reference memory impairment in aged rats . Journal of Pharmacological Sciences . 127 . 3 . 362–369 . March 2015 . 25837935 . 10.1016/j.jphs.2015.02.006 . free .
- Yamazaki M, Harada K, Yamamoto N, Yarimizu J, Okabe M, Shimada T, Ni K, Matsuoka N . 6 . ASP5736, a novel 5-HT5A receptor antagonist, ameliorates positive symptoms and cognitive impairment in animal models of schizophrenia . European Neuropsychopharmacology . 24 . 10 . 1698–1708 . October 2014 . 25108314 . 10.1016/j.euroneuro.2014.07.009 . free .
- Wu J, Li Q, Bezprozvanny I . Evaluation of Dimebon in cellular model of Huntington's disease . Molecular Neurodegeneration . 3 . 1 . 15 . October 2008 . 18939977 . 2577671 . 10.1186/1750-1326-3-15 . free .